(1)
FAVIPIRAVIR THERAPY FOR PATIENTS WITH COVID-19 PNEUMONIA: AN OBSERVATIONAL STUDY: Supawadee Suppadungsuk1 , Thananya Wongsinin1 , Sirawat Srichatrapimuk1 , Suppachok Kirdlarp1,2, Kulapong Jayanama1 , Kanin Thammavaranucupt1 , Dhanesh Pitidhammabhorn1 , Sithakom Phusanti1 , Nithita Nanthatanti1 and Somnuek Sungkanuparph1. SEATROPH 2021, 52 (1), 161-174.